NCT00901732

Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer

• Status: Unknown
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Jazz Pharmaceuticals · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Patients who have been diagnosed with a head and/or neck cancer commonly develop oral mucositis (OM). The purpose of this study is to estimate the effect of Caphosol on OM and to evaluate if Caphosol had any effect on clinical outcomes which include quality of life, oral intake, swallowing function and pain.

Conditions

• Oral Mucositis

Interventions

Type	Name	Description
DEVICE	Caphosol	Oral Mouth Rinse

Timeline

• Start date: 2009-05-01
• Primary completion: 2010-11-01
• Completion: 2010-11-01
• First posted: 2009-05-14
• Last updated: 2009-05-14

Locations

6 sites across 1 country: United States